Director, Protein Therapeutics
Brian Roberts is the Associate Director of Protein Therapeutics at EpiVax. Brian earned his PhD in Cell and Molecular Biology at the University of Vermont where his research focused on sex differences in viral autoimmunity. After leaving UVM he did a brief postdoc at the University of Connecticut working on CD8 T cell memory and Influenza. Following his time at UCONN, Brian began a post doc at EpiVax where he worked under the Tregitope group before assuming his position with Protein Therapeutics. In his current role, Brian oversees the immunogenicity screening of peptide drugs and their impurities under the Peptide Abbreviated New Drug Application (PANDA) program to support ANDA filings with the FDA.